IBRX
ImmunityBio, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:57 PM EST
6.72USD+7.348%(+0.46)15,869,693
Pre-marketNov 18, 2026 9:29:30 AM EST
6.28USD+0.319%(+0.02)
After-hoursNov 18, 2026 4:56:30 PM EST
6.73USD+0.149%(+0.01)
Loading…
Loading…
7.14B
Healthcare
Biotechnology
HQ
San Diego, CA, USA
703
Previous Close
$6.26
Beta
1.44
52-Week High
$12.43 2026-02-25
52-Week Low
$1.95 2025-12-31
SMA 50
$8.51
SMA 200
$7.97
Avg. Vol 10D
16.72M
Avg. Vol 30D
14.22M
Avg. Vol 90D
11.55M
Relative Vol
1.12
1.06B
410.68M
38.60%
126,083,790
109.45%
10.77
47%/53%
64.37%
50.58%
0.4900%
650,000
7,960
60,428
296,158
182.6M
-1.1B
-1.08
-296.7M
-150.16
132.84
Nov 18, 2026
Nov 17, 2026
Nov 16, 2026
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.
IBRX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.67 | 2026-11-11 | +0.60% | -3.257 |
| 1M | 8.42 | 2026-10-19 | -20.31% | 0.880 |
| 3M | 7.72 | 2026-08-18 | -13.08% | 1.404 |
| 6M | 8.00 | 2026-05-18 | -16.13% | 1.157 |
| 1Y | 2.10 | 2025-11-18 | +219.52% | 1.440 |
| 2Y | 5.01 | 2024-11-18 | +33.93% | — |
| 5Y | 6.53 | 2021-11-18 | +2.76% | 2.083 |
IBRX Stock Summary
ImmunityBio, Inc. Common Stock (NASDAQ:IBRX) stock price today is $6.71, and today's volume is 15,869,693. IBRX is up 7.188% today. The 30 day average volume is 14.22M. IBRX market cap is $7.14B with 1.06B shares outstanding.